MedPath
NMPA Approval

Lenalidomide Capsules

H20171347

May 9, 2019

H20171347

Drug Information

来那度胺胶囊

瑞复美

胶囊剂

15mg

化学药品

May 9, 2019

December 19, 2022

Company Information

Applicant Company

Winthontlaan 6 N, 3526KV Utrecht, The Netherlands

Manufacturing Company

Route de Perreux 1,2017 Boudry,Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

来那度胺胶囊 - NMPA 批准文号 | MedPath